In vivo binding of [68Ga]-DOTATOC to somatostatin receptors in neuroendocrine tumours — impact of peptide mass

« Previous Next »Nuclear Medicine and Biology
Volume 37, Issue 3 , Pages 265-275, April 2010

In vivo binding of [⁶⁸Ga]-DOTATOC to somatostatin receptors in neuroendocrine tumours — impact of peptide mass

Irina Velikyan
- Department of Biochemistry and Organic Chemistry, BMC, Uppsala University, Box 599, SE-751 24 Uppsala, Sweden
- Uppsala Applied Science Lab, GEMS PET Systems, GE Healthcare, SE-752 28 Uppsala, Sweden
Anders Sundin
- Department of Radiology, Karolinska University Hospital, SE-171 76 Stockholm, Sweden
Barbro Eriksson
- Department of Endocrine Oncology, Uppsala University Hospital, SE-751 85 Uppsala, Sweden
Hans Lundqvist
- Department of Oncology, Radiology and Clinical Immunology, Uppsala University, SE-751 85 Uppsala, Sweden
Jens Sörensen
- Department of Medicinal Sciences, Clinical Physiology and Nuclear Medicine, Uppsala University Hospital, SE-751 85 Uppsala, Sweden
Mats Bergström
- Department of Pharmaceutical Biosciences, Uppsala Biomedical Centre, Uppsala University, Uppsala, Sweden
Bengt Långström
- Department of Biochemistry and Organic Chemistry, BMC, Uppsala University, Box 599, SE-751 24 Uppsala, Sweden
- Corresponding author. PET Centre, Department of Biochemistry and Organic Chemistry, Uppsala University, Box 967, SE-751 09 Uppsala, Sweden. Tel.: +46 18 666900; fax: +46 18 666819.